The companies of Invalda AB group finance sector experienced the loss of 14.7 mLTL (4.26 mEUR) for 9 months of 2008, whereas for the same period of 2007 the companies..
MoreSanitas AB received the information from its shareholder Invalda AB that it has executed definitive documentation to transfer a 20.3 % interest in Sanitas AB to Baltic Pharma Limited, an..
MoreThe Management Board and major shareholders of Sanitas AB (“Sanitas” or the “Company”) initiated a strategic review in April 2008, to consider various strategic options available to the Company to..
MoreOn October 24, 2008, Invalda AB has signed an agreement regarding transfer of 6 314 502 shares, i.e. 20.3 % of share capital, of Sanitas AB for the total price..
MoreCenter for Drug Administration and Research of U.S. Food and Drug Administration (FDA) after the inspection of sterile pharmaceutical finished dosage manufacturing facility in Polish pharmaceutical company Jelfa SA classified..
MoreNet profit of Vilniaus baldai AB during September 2008 was 477 thousand LTL (138 thousand EUR), September of previous year – net profit of 174 thousand LTL (51 thousand EUR). EBITDA..
MoreAt the proposal of the president, the Lithuanian Parliament (Seimas) today approved the appointment of Lina Sajytė as a member of the Securities Commission. Ms Sajytė had been working as..
MoreFollowing the Board decision of Invalda AB 75 mLTL nominal value non-public bonds were issued. This issue will be refinanced in December 2008 by issuing non-public 25 mLTL and 50 mLTL..
MoreThe Board of Invalda AB approved the draft resolutions for the Extraordinary General Meeting of shareholders to be held on. On the agenda:1. Regarding non-public LTL 25 m convertible bonds..
More